A health economic analysis of the use of rhBMP-2 in Gustilo-Anderson grade III open tibial fractures for the UK, Germany, and France

Injury

Volumn 40, Issue 12, 2009, Pages 1269-1275

  Alt, Volker ^a   Donell, Simon T ^b   Chhabra, Amit ^c   Bentley, Anthony ^d   Eicher, Alexander ^a   Schnettler, Reinhard ^a  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^c Medtronic Sàrl ^*  (Switzerland)

^d Decision Resources Group   (United Kingdom)

Author keywords

Bone Morphogenetic Protein (BMP); Health economics; Tibial fracture

Indexed keywords

RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ARTICLE; AUTOGRAFT; BONE INFECTION; BONE TRANSPLANTATION; COST BENEFIT ANALYSIS; DEBRIDEMENT; FIBULA OSTEOTOMY; FRACTURE HEALING; FRANCE; GERMANY; HEALTH CARE COST; HEALTH CARE SYSTEM; HUMAN; INTRAMEDULLARY NAILING; LAVAGE; MAJOR CLINICAL STUDY; OPEN FRACTURE; ORTHOPEDIC SURGERY; OSTEOSYNTHESIS; PRIORITY JOURNAL; PRODUCTIVITY; SALARY; SOCIAL ASPECT; TIBIA FRACTURE; UNITED KINGDOM;

BONE MORPHOGENETIC PROTEINS; COST OF ILLNESS; COST SAVINGS; COST-BENEFIT ANALYSIS; EMPLOYMENT; FRACTURE FIXATION, INTRAMEDULLARY; FRACTURE HEALING; FRACTURES, OPEN; FRANCE; GERMANY; GREAT BRITAIN; HEALTH CARE COSTS; HUMANS; INCIDENCE; MODELS, ECONOMIC; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; REOPERATION; TIBIAL FRACTURES; TRANSFORMING GROWTH FACTOR BETA; TREATMENT OUTCOME;

EID: 70449700270     PISSN: 00201383     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.injury.2009.02.007     Document Type: Article

References (25)

1. Alt V., Eicher A., Bitschnau A., and Schnettler R. Cost-benefit analysis of the use of rhBMP-2 in open tibial fractures: savings from a health insurer's perspective. Unfallchirurg 109 (2006) 463-470 [German]
2. Alt V., and Heissel A. Economic considerations for the use of recombinant human Bone Morphogenetic Protein-2 in open tibial fractures in Europe: the German model. Curr Med Res Opin 22 Suppl. 1 (2006) 19-22
3. Court-Brown C.M. Reamed intramedullary tibial nailing: an overview and analysis of 1106 cases. J Orthop Trauma 18 (2004) 96-101
4. Dahabreh Z., Dimitriou R., and Giannoudis P.V. Health-economics: a cost analysis of treatment of persistent fracture non-union using Bone Morphogenetic Protein-7. Injury 38 (2007) 371-377
5. Eggli S., Scholl E., and Hertel R. Versorgung von IIIB offenen Unterschenkelfrakturen durch Frühosteosynthese und lokalen Muskellappen. Unfallchirurg 101 (1998) 674-683
6. Garrison K.R., Donell S., Ryder J., et al. Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review. Health Technol Assess 11 30 (2007)
7. Govender S, Csimma C, Genant HK, Valentin-Opran A, by the BMP-2 Evaluation in Surgery for Tibial Trauma (BESTT) Study Group. Recombinant human Bone Morphogenetic Protein-2 for treatment of open tibial fractures. A prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg 2002;84-A:2123-34.
8. Jones A.L. Recombinant human Bone Morphogenic Protein-2 in fracture care. J Orthop Trauma 19 10 (2005) S23-S25
9. Jones A.L., Swiontkowski M.F., Polly D.W., et al. Use of rhBMP-2 in the treatment of open tibial shaft fractures: do improved clinical outcomes outweigh the additional expense of rhBMP-2?. Orthopaedic Trauma Association Annual Meeting. Hollywood, FL (2004) [Scientific Poster 15]
10. Maetzel A., and Li L. The economic burden of low back pain: a review of studies published between 1996 and 2001. Best Pract Res Clin Rheumatol 16 (2002) 23-30
11. Malik M.H., Harwood P., Diggle P., and Khan S.A. Factors affecting rates of infection and nonunion in intramedullary nailing. J Bone Joint Surg 86-B (2004) 556-560
12. Maniadakis N., and Gray A. The economic burden of back pain in the UK. Pain 84 (2000) 95-103
13. No authors listed. The management of open tibial fractures. Published by: British Orthopaedic Association and British Association of Plastic Surgeons. www.boa.ac.uk/site/showpubliactions.aspx?ID=59 (last visited: 29/10/08).
14. No authors listed. http://www.legifrance.gouv.fr/ (last visited: 29/10/08).
15. No authors listed. www.dh.gov.uk (last visited: 29/10/08).
16. No author listed. www.oanda.com. (last visited: 29/10/08).
17. No authors listed. EUROSTAT. Retrieved on Wikipedia in May 2008.
18. No authors listed. www.cebm.net/levels_of_evidence.asp (last visited: 29/10/08).
19. Sanders R., Jersinovich I., Anglen J., et al. The treatment of open tibial shaft fractures using an interlocked intramedullary nail without reaming. J Orthop Trauma 8 (1994) 504-510
20. Schröder K. International Comparison of Labor Costs in Manufactuing. IW-Trends - Vierteljahresschrift zur empirischen Wirtschaftsforschung aus dem Institut der deutschen Wirtschaft Köln, 2006. p. 1-15.
21. Seferlis T., Lindholm L., and Nemeth G. Cost-minimisation analysis of three conservative treatment programmes in 180 patients sick-listed for acute low-back pain. Scand J Prim Health Care 18 (2000) 53-57
22. Soegaard R., and Christensen F.B. Health economic evaluation in lumbar spinal fusion: a systematic literature review anno 2005. Eur Spine J 15 (2006) 1165-1173
23. Sprague S., and Bhandhari M. An economic evaluation of early versus delayed operative treatment in patients with closed tibial shaft fractures. Arch Orthop Trauma Surg 122 (2002) 315-323
24. Szucs Th. Economic evaluation of technologies in health care. In: Szucs T., Haverich A., and Odar J. (Eds). Economics of surgical procedures (2000), JA Barth, Heidelbergand 3-4
25. Udvarhelyi I.S., Colditz G.A., Rai A., and Epstein A.M. Cost-effectiveness and cost-benefit analyses in the medical literature. Are the methods being used correctly?. Ann Intern Med 116 (1992) 238-244